Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; and EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, it provides da Vinci Single-Site, a set of non-wristed and wristed instruments and accessories that allow da Vinci Surgical Systems to work through a single incision. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System. It markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Phone408-523-2100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.72 billion
Profitability
Miscellaneous
Employees5,527
OptionableOptionable
Intuitive Surgical (NASDAQ:ISRG) Frequently Asked Questions
What is Intuitive Surgical's stock symbol?
Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."
When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?
Intuitive Surgical's stock split on Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.
How were Intuitive Surgical's earnings last quarter?
Intuitive Surgical, Inc. (NASDAQ:ISRG) released its quarterly earnings results on Thursday, January, 24th. The medical equipment provider reported $2.96 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $3.07 by $0.11. The medical equipment provider had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.05 billion. Intuitive Surgical had a return on equity of 18.11% and a net margin of 30.29%. The business's quarterly revenue was up 17.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.54 earnings per share. View Intuitive Surgical's Earnings History.
When is Intuitive Surgical's next earnings date?
What price target have analysts set for ISRG?
17 analysts have issued 1 year price targets for Intuitive Surgical's stock. Their forecasts range from $375.00 to $635.00. On average, they anticipate Intuitive Surgical's stock price to reach $575.00 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View Analyst Price Targets for Intuitive Surgical.
What is the consensus analysts' recommendation for Intuitive Surgical?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There are currently 1 sell rating, 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Intuitive Surgical.
What are Wall Street analysts saying about Intuitive Surgical stock?
Here are some recent quotes from research analysts about Intuitive Surgical stock:
- 1. According to Zacks Investment Research, "Intuitive Surgical ended the fourth quarter on a mixed note. While earnings fell short of estimates, revenues surpassed the same. The flagship da Vinci procedures also recorded solid growth in the quarter. The company looks to accelerate its business in China, following the clearance of da Vinci Xi. Management is also optimistic about the 510(k) submission for the TransOral Robotic Surgery and the Phase I launch of da Vinci SP. Intuitive Surgical outperformed the industry in a year’s time, courtesy of strong exposure to robotics & medical mechatronics. On the flip side, contraction in the company’s gross and operating margins is worrisome. Management expects margins to fluctuate due to newer product mixes and surging operating expenses. Additionally, the da Vinci system is in the early stages of adoption in some of the markets outside the United States. Intense competition in the global MedTech space adds to the woes." (1/30/2019)
- 2. Cantor Fitzgerald analysts commented, ": We reiterate our Overweight rating on shares of ISRG and maintain our PT of $620. ISRG reported 4Q18 results consistent with its preliminary announcement (1/9). ISRG delivered 19% procedure growth for 4Q18, largely driven by US general surgery and worldwide urology. ISRG reiterated its procedure growth guidance (13-17%), however we expect initial guidance to prove conservative as it has over the past several years. Management plans to increase opex by 20-28% in 2019, which comes as a surprise. We expect investors to have an initial negative reaction to the expected significant increase in spending, but we think the investments will fuel future top-line growth and accelerate ISRG’s pipeline." (1/25/2019)
- 3. Northland Securities analysts commented, "We are tweaking our models accordingly, and are introducing our FY20 numbers. Key Points Instrument & Accessory revs @ $539M vs. our estimate @ $535M. Systems revs @ $340M vs. our estimate @ $327M." (1/10/2019)
Has Intuitive Surgical been receiving favorable news coverage?
Press coverage about ISRG stock has been trending neutral this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Intuitive Surgical earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future.
Who are some of Intuitive Surgical's key competitors?
Some companies that are related to Intuitive Surgical include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX) and Invacare (IVC).
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the folowing people:
- Dr. Gary S. Guthart, CEO, Pres & Director (Age 53)
- Mr. Marshall L. Mohr, Exec. VP & CFO (Age 63)
- Mr. Salvatore J. Brogna, Exec. VP & COO (Age 64)
- Mr. David J. Rosa, Exec. VP & Chief Commercial Officer (Age 51)
- Dr. Myriam J. Curet McAdams, Exec. VP & Chief Medical Officer (Age 62)
Who are Intuitive Surgical's major shareholders?
Intuitive Surgical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Oregon Public Employees Retirement Fund (12.85%), BlackRock Inc. (7.27%), Bank of New York Mellon Corp (2.37%), Baillie Gifford & Co. (1.91%), Jennison Associates LLC (1.71%) and Geode Capital Management LLC (1.25%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.
Which major investors are selling Intuitive Surgical stock?
ISRG stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Carmignac Gestion, Baillie Gifford & Co., Canada Pension Plan Investment Board, Assenagon Asset Management S.A., Two Sigma Advisers LP, Mirae Asset Global Investments Co. Ltd. and State of Tennessee Treasury Department. Company insiders that have sold Intuitive Surgical company stock in the last year include Amal M Johnson, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.
Which major investors are buying Intuitive Surgical stock?
ISRG stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Jennison Associates LLC, Samlyn Capital LLC, Bank of Nova Scotia, Orbimed Advisors LLC, Eaton Vance Management and Thrivent Financial for Lutherans. View Insider Buying and Selling for Intuitive Surgical.
How do I buy shares of Intuitive Surgical?
Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intuitive Surgical's stock price today?
One share of ISRG stock can currently be purchased for approximately $548.50.
How big of a company is Intuitive Surgical?
Intuitive Surgical has a market capitalization of $62.80 billion and generates $3.72 billion in revenue each year. The medical equipment provider earns $1.13 billion in net income (profit) each year or $9.49 on an earnings per share basis. Intuitive Surgical employs 5,527 workers across the globe.
What is Intuitive Surgical's official website?
How can I contact Intuitive Surgical?
Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider can be reached via phone at 408-523-2100 or via email at [email protected]
MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe ISRG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISRG will underperform the S&P 500 over the long term. You may vote once every thirty days.
